SAUDI PHARMACEUTICAL SPI

SAUDI PHARMACEUTICAL INDUSTRIES (SPI) is a prominent pharmaceutical manufacturing company based in Saudi Arabia. It is primarily a factory, involved in the research, development, manufacturing, marketing, and distribution of a wide range of pharmaceutical products. SPI focuses on producing high-quality medicines for both the local Saudi market and international markets.

Company Introduction:

SAUDI PHARMACEUTICAL INDUSTRIES (SPI) is a leading pharmaceutical enterprise in Saudi Arabia, dedicated to advancing healthcare through the production of high-quality pharmaceutical products. Established with the vision of contributing to the well-being of the community, SPI operates state-of-the-art manufacturing facilities that adhere to international Good Manufacturing Practices (GMP) standards. The company's diverse portfolio includes a broad spectrum of therapeutic categories, covering generics, branded generics, and various dosage forms such as tablets, capsules, liquids, and injectables. SPI is committed to innovation, quality, and patient safety, continuously investing in research and development to bring effective and affordable medicines to market. Its robust distribution network ensures timely access to essential medications across Saudi Arabia and beyond.

Business Model:

SPI is a manufacturing company (factory).

The company SAUDI PHARMACEUTICAL SPI, which is identified as Saudi Pharmaceutical Industries and Medical Appliances Corporation SPIMACO ADDWAEIH, manufactures and sells products across several therapeutic categories. These include pharmaceuticals for the cardiovascular system, central nervous system, diabetes, gastrointestinal system, infectious diseases, musculoskeletal system, oncology, ophthalmology, respiratory system, urology, vitamins and nutrition, and dermatology. They also offer various over-the-counter products.